Kymera Therapeutics, Inc. (KYMR)
89.66
+1.85
(+2.11%)
USD |
NASDAQ |
Dec 12, 16:00
89.66
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Price: 89.66 for Dec. 12, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 120.38 |
| Regeneron Pharmaceuticals, Inc. | 741.48 |
| Sanofi | 48.67 |
| Cytokinetics, Inc. | 63.44 |
| TG Therapeutics, Inc. | 31.36 |
Price Related Metrics
| PS Ratio | 168.05 |
| PEG Ratio | -0.4576 |
| Price to Book Value | 6.817 |
| Earnings Yield | -4.01% |
| Market Cap | 6.451B |
| PEGY Ratio | -0.4576 |